Overview of innovative technology for treating ischemic and autoimmune disorders

Pluristem Therapeutics Inc. (NasdaqCM:PSTI)(DAX:PJT) today announced that it will present at the New England-Israel Life Sciences Summit at the Brandeis International Business School in Waltham, Mass. Zami Aberman, chairman and CEO of Pluristem will present an update on the company and an overview of its technology at 9:40 EDT, Oct 27, 2009.

“Selecting Pluristem to present at this conference is a recognition of our innovative technology and its potential to treat several severe ischemic and autoimmune disorders,” said Mr. Aberman. “Our ongoing clinical trials in the U.S. and Europe in patients with critical limb ischemia combined with our proprietary technology, position Pluristem as one of the leading companies in the cell therapy field, not only in Israel but also globally.”

The New England-Israel Life Sciences Summit will feature 15 Israeli life sciences companies that offer cutting edge technologies in the pharmaceuticals, biotechnology, medical devices and healthcare IT industries. The keynote speaker at the summit will be Mr. Israel Makov, Chairman, Given Imaging and former CEO of Teva Pharmaceutical Industries Ltd. Mr. Deval Patrick, the Honorable Governor of Massachusetts, will be the featured speaker.

http://www.pluristem.com/

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Online group programs aid weight loss but face hurdles